Treatment Processes in Psychosocial Rehab Services

描述(由申请人提供)：国家精神卫生研究所、总统精神卫生委员会、医学研究所和卫生局局长关于精神卫生的报告一致敦促所有服务都是有效的、公平的、以消费者为导向的，服务的目标不限于减轻症状，而是侧重于促进康复和赋权。本研究将使用一种混合的顺序解释设计，探讨参与社区心理社会康复服务的精神分裂症患者的消费者工作联盟、希望和心理社会功能结果之间的关系和因果关系；收集和分析量化数据，然后收集和分析定性数据，然后进行整合和集体解释。采用工作联盟问卷、赫斯·霍普指数和角色功能量表，随机抽取100名精神分裂症患者进行访谈。在收集和分析量化数据后，在工作联盟问卷上得分高(前1/3)的5个人和得分低(后1/3)的5个人将被有目的地抽样进行后续的开放式访谈，以探索导致他们的高和低评价的因素，并进一步调查来自定量数据的其他结果。在最后阶段，将对定量和定性数据进行并排比对。了解关键的治疗过程因素将导致改善治疗模式，以及更好的结果和提高精神分裂症患者的生活质量。

DESCRIPTION (provided by applicant): The National Institute of Mental Health, the President's Commission on Mental Health, the Institute of Medicine, and the Surgeon General's Report on Mental Health unanimously urge all services to be effective, equitable, consumer oriented, and for the goal of services to not be limited to symptom reduction but focused on promoting recovery and empowerment. The proposed study will examine the relationship and explore the causal ordering between consumer working alliance, hope, and psychosocial functioning outcomes of individuals with schizophrenia participating in community-based psychosocial rehabilitation services using a mixed methods sequential explanatory design; collection and analysis of quantitative data followed by the collection and analysis of qualitative data, which are subsequently integrated and interpreted collectively. 100 individuals diagnosed with schizophrenia randomly selected and interviewed using the Working Alliance Inventory, Herth Hope Index, and the Role Functioning Scale. After the quantitative data are collected and analyzed, five individuals who score high (top 1/3) and five individuals who score low (bottom 1/3) on the Working Alliance Inventory will be purposefully sampled for subsequent open-ended interviews to explore factors that contributed to their high and low evaluations and further investigate the other results from the quantitative data. In the final stage, the quantitative and qualitative data will be compared side-by-side. Understanding the critical treatment process factors will lead to improved treatment models as well as better outcomes and enhanced quality of lives for individuals with schizophrenia.